Stacy Lindborg insider trades
Open-market stock purchases and sales by Stacy Lindborg, President and CEO at Imunon, Inc, from SEC Form 4 filings since Jun 1, 2020.
Track record: 50% of 2 scored buys are up 5% or more since purchase, averaging -3%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Oct 9, 2026 | IMNN Imunon, Inc | Bought (not open market) | $3.2K |
| Sep 25, 2026 | IMNN Imunon, Inc | Bought (not open market) | $9.4K |
| Sep 11, 2026 | IMNN Imunon, Inc | Bought (not open market) | $8.1K |
| Aug 28, 2026 | IMNN Imunon, Inc | Bought (not open market) | $10.9K |
| Aug 14, 2026 | IMNN Imunon, Inc | Bought (not open market) | $10.9K |
| Jul 31, 2026 | IMNN Imunon, Inc | Bought (not open market) | $8K |
| Jul 17, 2026 | IMNN Imunon, Inc | Bought (not open market) | $9K |
| Jul 2, 2026 | IMNN Imunon, Inc | Bought (not open market) | $4.8K |
| Jun 25, 2026 | IMNN Imunon, Inc | Bought (not open market) | $115K |
| Jun 18, 2026 | IMNN Imunon, Inc | Bought (not open market) | $3.3K |
| Jun 5, 2026 | IMNN Imunon, Inc | Bought (not open market) | $3.3K |
| May 22, 2026 | IMNN Imunon, Inc | Bought (not open market) | $3.3K |
| Feb 26, 2026 | BCLI Brainstorm Cell Therapeutics Inc | Bought (not open market) | $105K |
| Jan 2, 2026 | IMNN Imunon, Inc | Bought (not open market) | — |